198 related articles for article (PubMed ID: 7140630)
1. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
[No Abstract] [Full Text] [Related]
2. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
Zatz M; Otto PA
Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
[TBL] [Abstract][Full Text] [Related]
4. Duchenne's muscular dystrophy: carrier detection by muscle ultrasound.
Rott HD; Mulz D
J Genet Hum; 1983 Mar; 31(1):63-5. PubMed ID: 6619807
[No Abstract] [Full Text] [Related]
5. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
[TBL] [Abstract][Full Text] [Related]
6. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
Passos MR; Gonzalez CH; Zatz M
Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
[TBL] [Abstract][Full Text] [Related]
7. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
Krasil'nikov VV; Labeznik TA; Shilov LA
Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
[TBL] [Abstract][Full Text] [Related]
8. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
[TBL] [Abstract][Full Text] [Related]
9. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
Zatz M; Passos MR; Bortolini ER
Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
[No Abstract] [Full Text] [Related]
10. [Progress in heterozygote detection in muscular dystrophy].
Hausmanowa-Petrusewicz I
Neurol Neurochir Pol; 1981; 15(1):1-4. PubMed ID: 7254468
[No Abstract] [Full Text] [Related]
11. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
Muir WA; Knoke J; Martin A; Vignos P; McErlean A
Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
[TBL] [Abstract][Full Text] [Related]
12. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
[TBL] [Abstract][Full Text] [Related]
13. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
Ionasescu V; Burmeister L; Hanson J
Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
[TBL] [Abstract][Full Text] [Related]
14. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
Beckmann R
Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
[No Abstract] [Full Text] [Related]
15. Quantitative EMG as a method of carrier detection in X-linked muscular dystrophy.
Gardner-Medwin D
Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):401. PubMed ID: 4176582
[No Abstract] [Full Text] [Related]
16. [Echoscopic diagnosis of the heterozygote carrier state in Duchenne's muscular dystrophy].
Krasil'nikov VV; Lazebnik TA; Prokof'ev GV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):18-9. PubMed ID: 3066080
[TBL] [Abstract][Full Text] [Related]
17. The detection of female carriers of pseudohypertrophic muscular dystrophy.
Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
[No Abstract] [Full Text] [Related]
18. Genotype prediction in Duchenne muscular dystrophy.
Lancet; 1985 Jun; 1(8442):1391-2. PubMed ID: 2861340
[No Abstract] [Full Text] [Related]
19. Macroemg in manifesting carriers of Duchenne muscular dystrophy.
Szmidt-Sałkowska E; Rowiñska-Marciñska K; Fidziañska A; Hausmanowa-Petrusewicz I
Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):87-92. PubMed ID: 10207677
[TBL] [Abstract][Full Text] [Related]
20. [Individualization of carriers of Duchenne's muscular dystrophy . Problems and prospectives].
Comi G; Comola M; Galardi G; Piattoni F; Erembourg L; Canal N
Minerva Pediatr; 1986 Aug; 38(15-16):625-32. PubMed ID: 3796511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
